Pinnacle Associates LTD Bristol Myers Squibb CO Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pinnacle Associates LTD holds 266,041 shares of BMY stock, worth $15.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

266,041

Previous 195,136 36.34%

Holding current value

$15.3 Million

Previous $8.1 Million 69.9%

% of portfolio

0.22%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$39.66 - $51.75 $2.81 Million - $3.67 Million	70,905 Added 36.34%	266,041 $13.8 Million
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $246,370 - $324,351	-6,121 Reduced 3.04%	195,136 $8.1 Million
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $3.11 Million - $3.52 Million	-64,784 Reduced 24.35%	201,257 $10.9 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $7 Million - $8.35 Million	-144,388 Reduced 35.18%	266,041 $13.7 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $600,203 - $671,120	-10,368 Reduced 2.46%	410,429 $23.8 Million
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $9.96 Million - $11.1 Million	156,281 Added 59.08%	420,797 $26.9 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $58,481 - $66,331	-890 Reduced 0.34%	264,516 $18.3 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $17,667 - $20,921	-258 Reduced 0.1%	265,406 $19.1 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $168,255 - $199,238	-2,457 Reduced 0.92%	265,664 $0
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $910 - $538,417	-7,007 Reduced 2.55%	268,121 $19.1 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $138,341 - $152,361	1,905 Added 0.7%	275,128 $21.2 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $1.12 Million - $1.35 Million	-18,257 Reduced 6.26%	273,223 $20 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $807,667 - $941,551	-15,060 Reduced 4.91%	291,480 $18.2 Million
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $782,937 - $917,109	-13,232 Reduced 4.14%	306,540 $18.1 Million
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $753,568 - $820,636	-12,172 Reduced 3.67%	319,772 $21.4 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $830 - $934	-14 Reduced -0.0%	331,944 $21 Million
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $1.3 Million - $1.47 Million	-22,539 Reduced 6.36%	331,958 $20.6 Million
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $1.11 Million - $1.23 Million	19,299 Added 5.76%	354,497 $21.4 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $28,396 - $33,198	-518 Reduced 0.15%	335,198 $19.7 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $1.41 Million - $2.05 Million	30,334 Added 9.93%	335,716 $18.7 Million
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $3.26 Million - $4.26 Million	66,303 Added 27.73%	305,382 $19.6 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $186,263 - $220,842	4,355 Added 1.86%	239,079 $12.1 Million
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $157,999 - $174,712	-3,541 Reduced 1.49%	234,724 $10.6 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $442,897 - $528,100	9,816 Added 4.3%	238,265 $11.4 Million
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $593,409 - $769,509	-12,170 Reduced 5.06%	228,449 $11.9 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $271,810 - $306,581	-4,925 Reduced 2.01%	240,619 $14.9 Million
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $59,170 - $73,749	1,171 Added 0.48%	245,544 $13.6 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $36,551 - $42,077	610 Added 0.25%	244,373 $15.5 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $548,870 - $598,409	9,157 Added 3.9%	243,763 $14.9 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $2.08 Million - $2.4 Million	-37,618 Reduced 13.82%	234,606 $15 Million
Q2 2017 Aug 09, 2017	BUY	N/A	272,224	272,224 $15.2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Bristol Myers Squibb CO Transaction History